The immunologic role of thymectomy in the treatment of myasthenia gravis: implication of thymus-associated B-lymphocyte subset in reduction of the anti-acetylcholine receptor antibody titer.

MLA

Okumura, Meinoshin, et al. “The Immunologic Role of Thymectomy in the Treatment of Myasthenia Gravis: Implication of Thymus-Associated B-Lymphocyte Subset in Reduction of the Anti-Acetylcholine Receptor Antibody Titer.” The Journal of Thoracic and Cardiovascular Surgery, vol. 126, no. 6, Dec. 2003, pp. 1922–28. EBSCOhost, https://doi.org/10.1016/s0022-5223(03)00938-3.

APA

Okumura, M., Ohta, M., Takeuchi, Y., Shiono, H., Inoue, M., Fukuhara, K., Kadota, Y., Miyoshi, S., Fujii, Y., & Matsuda, H. (2003). The immunologic role of thymectomy in the treatment of myasthenia gravis: implication of thymus-associated B-lymphocyte subset in reduction of the anti-acetylcholine receptor antibody titer. The Journal of Thoracic and Cardiovascular Surgery, 126(6), 1922–1928. https://doi.org/10.1016/s0022-5223(03)00938-3

Chicago

Okumura, Meinoshin, Mitsunori Ohta, Yukiyasu Takeuchi, Hiroyuki Shiono, Masayoshi Inoue, Kenjiro Fukuhara, Yoshihisa Kadota, Shinichiro Miyoshi, Yoshitaka Fujii, and Hikaru Matsuda. 2003. “The Immunologic Role of Thymectomy in the Treatment of Myasthenia Gravis: Implication of Thymus-Associated B-Lymphocyte Subset in Reduction of the Anti-Acetylcholine Receptor Antibody Titer.” The Journal of Thoracic and Cardiovascular Surgery 126 (6): 1922–28. doi:10.1016/s0022-5223(03)00938-3.